Company confirms 12 patients enrolled in Phase 2 THIO-101 to date as expansion trial adds new countries Posters for Phase 2 and Phase 3 clinical trials available CHICAGO, Nov. 21, 2025 (GLOBE NEWSWIRE ...
Internal records reveal that for years Penn State’s clinical cancer research was mired in deep-rooted and potentially ...
Company confirms 12 patients enrolled in Phase 2 THIO-101 to date as expansion trial adds new countries Posters for Phase 2 and Phase 3 clinical ...
Detailed price information for Kezar Life Sciences Inc (KZR-Q) from The Globe and Mail including charting and trades.
MAIA Biotechnology (MAIA) announced highlights from two poster presentations delivered at SITC 2025, an annual conference hosted by the Society ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback